curve guardian glp-1 receptor agonist and risk of erectile dysfunction in men with type 2 diabetes: a target trial emulation A new Science Perspective highlights

Data was sourced from the TriNetX research network, encompassing 101 hospital systems, and researchers identified two groups to analyze

Many patients wonder if GLP-1 therapy must be lifelong or if short-term use can deliver lasting results

Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner

Glucose-dependent insulinotropic polypeptide (GIP) is an intestinal hormone that potentiates glucose-induced insulin secretion in the postprandial state

Learn why the FDA says these products werent FDA-approved and how you could recover money.

Active adults, recreational athletes, and people working through physical therapy are now using them to improve body composition, and the results on weight loss are real